VISICOIL™
Linear Fiducial Markers
See it. Trust it. Treat it.
VISICOIL™ is a flexible linear fiducial marker for use with today’s most accurate image-guided radiotherapy treatment plans.
VISICOIL™ is a flexible linear fiducial marker for use with today’s most accurate image-guided radiotherapy treatment plans.
VISICOIL™ MR imaging markers for soft tissue tumor localization provide enhanced accuracy in radiation therapy planning and delivery. The new multi-modality linear fiducial marker offers high visibility in MRI & CT (and more) image modalities allowing for efficient MR/CT fusion and IGRT.
The various sizes and hollow core of VISICOIL™ reduces the image artifact caused by solid gold markers in many imaging machines. Reduced artifact aids by decreased processing time, more precise contouring. This also help in hypofractionation where escalated dosing and tighter margins are required.
The helical design of VISICOIL™ provides extreme flexibility of the marker. This allows the marker to easily be placed in delicate tissues such as the Pancreas, Liver, Lung, Cervix, Breast, Bladder, and more. The flexible VISICOIL™ markers conforms and moves with deformable tissue potentially helping to mitigate migration.
Today’s high tech imaging equipment and accurate treatment capabilities should no longer rely on 1st generation fiducial markers. With escalated dosing and tighter margins, the need for improved marker reliability to treat your patients with confidence is clear. VISICOIL™ has demonstrated excellent stability in soft tissue with visibility needed to optimize their capabilities. When top manufacturers of these machines and associated devices need a marker to demonstrate how well their equipment works, they choose VISICOIL™.
Using an x-ray based IGRT system the VISICOIL™ markers are tracked prior to treatment for initial precise patient set-up. For lung and liver cases with tumor motion larger than 10 mm VISICOIL™ is used to track breathing induced motion during gated treatment delivery.
VISICOIL™ fiducial markers are widely used in radiation therapy and IGRT. Over 10,000 patients annually benefit from higher targeting accuracy.
— Reinhard Wurm M.D., Chairman Radiation Oncology / Klinikum Frankfurt Oder, Germany